These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17047652)

  • 21. Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
    Azuma Y; Sato H; Higai K; Matsumoto K
    Biol Pharm Bull; 2007 Sep; 30(9):1680-4. PubMed ID: 17827720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.
    Zhang JZ; Cavet ME; Ward KW
    Curr Eye Res; 2008 Nov; 33(11):923-32. PubMed ID: 19085374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC
    Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viscum articulatum Burm. f. aqueous extract exerts antiproliferative effect and induces cell cycle arrest and apoptosis in leukemia cells.
    Mishra R; Sharma S; Sharma RS; Singh S; Sardesai MM; Sharma S; Mishra V
    J Ethnopharmacol; 2018 Jun; 219():91-102. PubMed ID: 29555410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the topoisomerase II-DNA cleavable complex by the ortho-quinone derivative of the antitumor drug etoposide (VP-16).
    Gantchev TG; Hunting DJ
    Biochem Biophys Res Commun; 1997 Aug; 237(1):24-7. PubMed ID: 9266822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
    Wang SJ; Peyrollier K; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide.
    Herzog CE; Zwelling LA; McWatters A; Kleinerman ES
    Clin Cancer Res; 1995 Nov; 1(11):1391-7. PubMed ID: 9815936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between decreased sensitivity of the Daudi lymphoma cells to VP-16-induced apoptosis and deficiency in DNAS1L3 expression.
    Boulares H; Zoltoski A; Kandan S; Akbulut T; Yakovlev A; Oumouna M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):653-62. PubMed ID: 16427601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line.
    Vellenga E; Asschert L; Withoff S; van der Kolk D; de Vries EG
    Leukemia; 1994 Dec; 8(12):2060-4. PubMed ID: 7807995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta.
    Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES
    Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK; Murray NR; Allan WP; Fields AP; Yalowich JC
    Mol Pharmacol; 1995 Nov; 48(5):798-805. PubMed ID: 7476909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of etoposide induced cell killing by hyperthermia can occur without changes in etoposide transport or DNA topoisomerase II activity.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Hyperthermia; 1996; 12(4):551-67. PubMed ID: 8877478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
    Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
    Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.
    Brillault J; De Castro WV; Harnois T; Kitzis A; Olivier JC; Couet W
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1457-62. PubMed ID: 19188390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes.
    Aoyama M; Grabowski DR; Holmes KA; Rybicki LA; Bukowski RM; Ganapathi MK; Ganapathi R
    Biochem Pharmacol; 2001 Jan; 61(1):49-54. PubMed ID: 11137708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage response to apoptotic cells varies with the apoptotic trigger and is not altered by a deficiency in LRP expression.
    Kozmar A; Greenlee-Wacker MC; Bohlson SS
    J Innate Immun; 2010; 2(3):248-59. PubMed ID: 20375555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.